drug
amphotericin B
Marketedupdated 3mo agoby Astellas Pharma US Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying amphotericin B
- phase3Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST)
- phase1Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA)
- N/AHuman Bioequivalence Study of Liposomal Amphotericin B for Injection
- —A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis
- phase3Olorofim Aspergillus Infection Study
- phase2A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis
- N/AHuman Bioequivalence Study of Amphotericin B Liposome for Injection
- phase3A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 18m ago
Found something off?
comments(0)
5-min edit window · permanent after that